Flörkemeier, I.; Hotze, H.L.; Heyne, A.L.; Hildebrandt, J.; Weimer, J.P.; Hedemann, N.; Rogmans, C.; Holthaus, D.; Siebert, F.-A.; Hirt, M.;
et al. Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma. Int. J. Mol. Sci. 2025, 26, 2829.
https://doi.org/10.3390/ijms26072829
AMA Style
Flörkemeier I, Hotze HL, Heyne AL, Hildebrandt J, Weimer JP, Hedemann N, Rogmans C, Holthaus D, Siebert F-A, Hirt M,
et al. Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma. International Journal of Molecular Sciences. 2025; 26(7):2829.
https://doi.org/10.3390/ijms26072829
Chicago/Turabian Style
Flörkemeier, Inken, Hannah L. Hotze, Anna Lena Heyne, Jonas Hildebrandt, Jörg P. Weimer, Nina Hedemann, Christoph Rogmans, David Holthaus, Frank-André Siebert, Markus Hirt,
and et al. 2025. "Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma" International Journal of Molecular Sciences 26, no. 7: 2829.
https://doi.org/10.3390/ijms26072829
APA Style
Flörkemeier, I., Hotze, H. L., Heyne, A. L., Hildebrandt, J., Weimer, J. P., Hedemann, N., Rogmans, C., Holthaus, D., Siebert, F.-A., Hirt, M., Polten, R., Morgan, M., Klapdor, R., Schambach, A., Dempfle, A., Maass, N., van Mackelenbergh, M. T., Clement, B., & Bauerschlag, D. O.
(2025). Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma. International Journal of Molecular Sciences, 26(7), 2829.
https://doi.org/10.3390/ijms26072829
